Validation of relative mRNA expression of FOXM1 in HTII-280+-derived organoids cultivated in CHIR and AOM medium in two different donor lines confirmed the positive effect of the CHIR99201 treatment (Supplementary Fig. 3g). This evidence concerns the gene FOXM1 and infectious otitis media.